Market

Close Price

You can view full text of the latest Director's Report for the company.

DIRECTORS' REPORT

Abate As Industries Ltd.

GO
Market Cap. ( ₹ in Cr. ) 136.80 P/BV 0.78 Book Value ( ₹ ) 11.14
52 Week High/Low ( ₹ ) 20/8 FV/ML 10/1 P/E(X) 15.96
Book Closure 31/07/2025 EPS ( ₹ ) 0.54 Div Yield (%) 0.00
Year End :2026-03 

The Board of Directors present the Company's 35th Annual Report and the Company's audited financial
statements for the financial year ended March 31,2026.

FINANCIAL SUMMARY AND HIGHLIGHTS:

The Company's financial performance (standalone and consolidated) for the year ended March 31,2026 is
summarized below:

(Amount In Lakhs)

Standalone

Consolidated

Sr No.

Particulars

As on 31/03/2026

As on 31/03/2025

As on 31/03/2026

As on 31/03/2025

1.

Revenue from Operations

-

-

15,940

1,408.68

2.

Other Income

211.55

97.04

23.279

96.6

3.

Expenses

56.82

42.17

14,903.30

1395.88

4.

Profit/(loss) before
exceptional items & tax

154.73

54.33

1,270.36

109.4

5.

Profit/(loss) Before Tax

154.73

54.33

1,270.36

108.56

6.

Tax expense

-

-

71.63

1.49

7.

Profit/ (Loss) for the period

154.33

54.33

1,229.71

110.05

RESULTS OF OPERATION AND THE STATE OF THE COMPANY'S AFFAIRS:

During the year under review, the Company has made a standalone profit of Rs. 154.73 lakhs and
consolidated profit of Rs. 1229.71 lakhs for FY 2025-26 as compared to operating (Standalone) profit of Rs.
54.33 Lakhs in the previous year.

CHANGE IN NATURE OF BUSINESS:

There is no change in the nature of business of your Company, during the year under review.

SHARE CAPITAL:

A. Increase in Authorised Share Capital and Alteration of Capital Clause of MoA:

During the financial year under review, the Authorised Share Capital of your Company was increased twice
to accommodate the corporate growth strategies and capital requirements. The details of the revisions are
outlined below:

First Increase: The Authorised Share Capital was increased from the existing ?95,00,00,000/- (Rupees Ninety-
Five Crore only) divided into 9,50,00,000 (Nine Crore Fifty Lakh) Equity Shares of ?10/- each to
? 1,58,00,00,000/- (Rupees One Hundred and Fifty-Eight Crore only) divided into 15,80,00,000 (Fifteen Crore
Eighty Lakh) Equity Shares of ?10/- each. This variation was approved by the members of the Company by
way of a Special Resolution passed in the Annual General Meeting held on 14th July 2025, resulting in the
substitution of Clause V (Capital Clause) of the Memorandum of Association (MoA).

Second Increase: To facilitate further strategic initiatives, the Authorised Share Capital was subsequently
increased from ? 1,58,00,00,000/- (Rupees One Hundred and Fifty-Eight Crore only) to ?2,00,00,00,000/-
(Rupees Two Hundred Crore only) divided into 20,00,00,000 (Twenty Crore) Equity Shares of ?10/- each. This
further alteration of Clause V of the MoA was approved by the members by way of a Special Resolution
passed through Postal Ballot on 20th November 2025.

B. Issue and Allotment of Bonus Shares:

During the year under review, In order to reward the members for their continued trust and support, your
Company your Company has allotted 78,88,03,228 (seven crore eighty-eight lakhs three thousand two
hundred and twenty-eight) fully paid-up Equity Shares of ?10/-(Rupeess Ten Only) each as bonus issue in the
ratio of 1:1 (i.e., 1 (One) new fully paid-up Equity Share for every 1 (One) existing fully paid-up Equity Share
held by capitalization of free reserves/securities premium account a sum not exceeding ?78,80,32,280/-
(Rupees Seventy-Eight Crore Eighty Lakh Thirty-Two Thousand Two Hundred and Eighty only)

The Bonus Issue was approved by the shareholders of the Company in the Annual General Meeting held on
14th July 2025 and the allotment of bonus shares was made on August 01,2025. Consequently, the paid-up
equity share capital of the Company increased from ? 78,80,32,280/- (Rupees Seventy-Eight Crore Eighty
Lakh Thirty-Two Thousand Two Hundred and Eighty only) comprising 7,88,03,228 (seven crore eighty-eight
lakhs three thousand two hundred and twenty-eight) equity shares of Rs. 10 (Rupees Ten only) each to ?
157,60,64,560/-(Rupees One Fifty Seven Crore Sixty Lakh Sixty Four Thousand Five Hundred and Twenty Eighty
only) comprising 15,76,06,456 (Fifteen Crore Seventy-Six Lakhs six thousand four hundred and fifty-six) shares
equity shares Rs. 10 (Rupees Ten only) each

The newly issued Bonus Shares rank pari-passu in all respects with the existing equity shares of the Company.
Any fractional entitlements resulting from the 1:1 issuance were rounded down to the lower integer in
accordance with the regulatory approvals. The Company successfully completed the credit of these shares
into the respective demat accounts of the shareholders and obtained necessary listing and trading
approvals from the Stock Exchange(s).

PARTICULARS OF SUBSIDIARIES, ASSOCIATES AND JOINT VENTURE COMPANIES:

The strategic allotment of equity shares on a preferential basis through a swap of shares executed on
February 25, 2025, your Company's corporate structure expanded to include three (3) Subsidiary
Companies and one (1) Associate Company.

A. Corporate Structure & Alignments:

The composition of the Group at the close of the financial year is outlined below:

Subsidiary Companies:

• M/s. Salamath Import & Exports Private Limited (Incorporated in India)

• M/s. Prudential Management Services Private Limited (Incorporated in India)

• M/s. Sky International Trading WLL (Incorporated in Bahrain)

Associate Company:

• M/s. SAIA Educational Support Services WLL (Incorporated in Bahrain)

Joint Ventures:

• Your Company does not have any Joint Venture agreements or entities as of March 31,2026.

B. Changes in the Group Structure during the Year:

Other than the initial acquisitions via share swap completed on February 25, 2025, no other companies
have become or ceased to be Subsidiaries, Joint Ventures, or Associate companies during the financial
year under review.

C. Consolidated Financial Statements & AOC-1:

In compliance with Section 129(3) of the Companies Act, 2013, and applicable Accounting Standards, the
Audited Consolidated Financial Statements of the Company and all its subsidiaries form an integral part of
this Annual Report.

A separate statement containing the salient features of the financial statements of our Subsidiaries and
Associate company in the prescribed Form AOC-1 is annexed to this Report.

D. Performance Highlights and Financial Contribution:

The performance highlights and operational summary of the individual corporate components are as
follows:

During the year ended 31 March 2026, the Group continued to maintain stable operations across its
constituent entities and reported consolidated total income of ^1,617.37 million, including revenue from
operations of ?1,594.09 million.

Sky remained the largest contributor to the Group's performance, generating revenue from operations of
?1,234.50 million and accounting for the majority of the Group's consolidated turnover. The entity continued
to be the primary driver of business activity and revenue generation during the period.Prudential reported
revenue from operations of ?309.50 million and demonstrated consistent operational performance,
contributing meaningfully to the Group's consolidated results.Salamath recorded revenue from operations
of ?60.38 million and maintained steady business operations during the reporting period.Abate AS reported
other income of ?21.16 million.

Inter-company transactions amounting to ? 10.30 million were eliminated upon consolidation to present the
financial performance of the Group as a single economic entity in accordance with the applicable
accounting standards.

Overall, the Group's performance during the period was supported by the strong revenue contribution from
Sky, complemented by stable contributions from Prudential and Salamath, resulting in a robust consolidated
income base.

E. Public and Shareholder Accessibility of Accounts:

In terms of Section 136 of the Companies Act, 2013, the audited financial statements, including the
consolidated financial statements and separate audited accounts in respect of each of its subsidiaries,
have been placed on the official website of the Company and can be accessed at: Weblink:
https://abateas.com/annual-account-of-subsidiaries/

The annual accounts of the subsidiary companies will be made available to any shareholder of the
Company upon formal request. These documents are also open for physical inspection by any member at
the Registered Office of the Company during business hours on all working days.

SUSPENSION OF TRADING OF SECURITIES:

In terms of the disclosures required under Schedule V (C)(6)(9)(h) of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, the Board of Directors explicitly confirms that the equity shares
of the Company have not been suspended from trading on any Stock Exchange where they are listed
during the financial year under review. The securities remain active and traded in compliance with
regulatory mandates.

STATEMENT OF DEVIATION(S) OR VARIATION(S).

A. Disclosure of Statement of Deviation(s) or Variation(s) (Regulation 32(4)):

Pursuant to Regulation 32(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
the Company confirms that there has been no deviation or variation in the utilization of the
objects/consideration stated in the explanatory statement to the notice of the Extraordinary General
Meeting (EGM) held on February 05, 2025, for the preferential allotment of 7,37,87,128 Equity Shares. The
necessary quarterly statements confirming zero deviation were duly submitted to the Stock Exchange(s)
within the prescribed statutory timelines.

B. Note on Utilization of Funds / Consideration Raised through Preferential Allotment (Regulation 32(7A)):

In compliance with Regulation 32(7A) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, the Board of Directors reports the status and utilization of the consideration relating to the
Preferential Allotment:

Note on Preferential Allotment and Consideration (Other than Cash):

Consequent to the approval accorded by the members at the Extraordinary General Meeting held on
February 05, 2025, the Company issued and allotted 7,37,87,128 Equity Shares of face value of ?10/- each
on a preferential basis to Promoter and Non-Promoter Investors on February 25, 2025.

As disclosed in the object of the issue, this preferential allotment was executed for consideration other than
cash via a share swap mechanism. The allotment served to acquire equity stakes in the respective target
entities, thereby transitioning them into subsidiaries/associates of the Company.

Since the transaction was structured purely as a share swap for business consolidation, no liquid cash funds
were raised by the Company under this Preferential Allotment. The non-cash consideration (equity shares of
the target companies) has been fully and completely utilized towards the designated strategic investment
objects as of March 31,2025, leaving no unutilized balance or funds carried forward.

DIVIDEND:

A. Dividend Declaration for the Financial Year 2025-2026:

With a view to conserving internal financial resources to support ongoing strategic expansions, strengthen
working capital, and fuel the future business operations of the Group, your Director's deem it prudent not to
recommend any dividend on the Equity Shares of the Company for the financial year ended March 31,
2026.

B. Dividend Distribution Policy & Web Link:

In terms of Regulation 43A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
the mandatory formulation and disclosure of a formal Dividend Distribution Policy is applicable only to the
top 1,000 listed entities based on market capitalization calculated as of March 31 of every financial year.
Since your Company does not fall within the specified threshold of the top 1,000 listed entities, the
formulation of the said policy is not applicable to the Company, and consequently, no such policy has
been adopted or hosted on the website.

TRANSFER TO RESERVES:

During the financial year under review, your Company proposed to transfer an amount of ? 154.73 Lakhs to
the Retained Earnings out of the current profits available for appropriation.

DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS
IMPACTING THE GOING CONCERN STATUS AND COMPANY'S OPERATIONS IN FUTURE:

During the financial year 2025-2026 under review, there were no significant or material orders passed by any
Regulators, Courts and Tribunals that would impact the going concern status of your Company or
potentially jeopardise its future business operations.

Your Company maintains a robust legal and regulatory compliance framework to ensure all operational
tracks conform entirely to applicable laws and guidelines.

PUBLIC DEPOSITS:

During the financial year 2025-2026 under review, your Company has neither invited nor accepted any
deposits from the public within the meaning of Section 73 and Section 76 of the Companies Act, 2013, read
along with the Companies (Acceptance of Deposits) Rules, 2014.

Accordingly, the specific disclosures required under Rule 8(5)(v) & (vi) of the Companies (Accounts) Rules,
2014 are outlined below:

Statutory Disclosure Requirements

Status / Particulars

(a) Deposits accepted during the year

Nil

(b) Deposits remained unpaid or unclaimed as at the end of the year

(c) Default in repayment of deposits or payment of interest thereon during the year

Nil

(i) At the beginning of the year

Nil

(ii) Maximum during the year

Nil

(iii) At the end of the year

Nil

(d) Details of deposits which are not in compliance with the requirements of Chapter
V of the Act

Nil

MATERIAL CHANGES AND COMMITMENTS AFFECTING THE FINANCIAL POSITION OF THE COMPANY:

There have been no material changes and commitments affecting the financial position of the Company
that occurred between the end of the financial year to which the financial statements relate (i.e., March
31,2026) and the date of approval of this Board's Report.

The operations and fiscal trajectory of your Company continue to remain steady and aligned with the
reported financial figures.

PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS MADE UNDER SECTION 186 OF THE COMPANIES ACT,
2013:

During the financial year 2025-2026 under review, your Company has not given any loans, extended any
guarantees, or provided any securities as covered under the provisions of Section 186 of the Companies
Act, 2013.

Additionally, the Company has not made any new investments during the year that would attract
disclosures under the said section. All existing investments/stakes held by the Company are within the
permissible limits and are duly reflected in the notes forming part of the Standalone Financial Statements.

INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY:

Your Company has established a robust and comprehensive Internal Financial Controls (IFC) framework
designed to ensure the orderly and efficient conduct of its business, safeguarding of its assets, prevention
and detection of frauds and errors, accuracy and completeness of the accounting records, and the timely
preparation of reliable financial disclosures.

In accordance with Rule 8(5) (viii) of the Companies (Accounts) Rules, 2014, the Board of Directors confirms
that the Company maintains adequate internal financial control systems tailored to monitor business
processes, structural financial reporting, and strict compliance with applicable statutory regulations. These
systems are thoroughly integrated into the daily operations of the Company and were operating effectively
throughout the financial year 2025-2026 under review.

DIRECTORS & KEY MANAGERIAL PERSONNEL:

Dr. Adv Arikuzhiyan Samsudeen (DIN: 01812828)

: Chairman & Non-Executive Director

Dr. Muhemmed Swadique (DIN: 02933064)

: Whole Time Director

Ms. Julie G Varghese (DIN: 09274826)

: Non-Executive Independent Director

Dr. Musallyarakatharakkal Safarulla (DIN: 02933030)

: Non-Executive Director

Mr. Mohammed Kutty Arikuzhiyil (DIN: 02007636)

: Non-Executive Director

Mr. Abdul Nazar Jamal Kizhisseri Muhammed (DIN: 06990053)

: Non-Executive Director

Dr. Rajesh Puthussery (DIN: 09270524)

: Non-Executive Director

Mrs. Indu Ravindran (DIN: 09252600)

: Non-Executive Independent Director

Mrs. Manjusha Ramakrishnan Puthenpurakkal (DIN: 09427053)

: Non-Executive Independent Director

Mr. Eramangalath Gopalakrishna Panicker Mohankumar (DIN: 00722626)

: Non-Executive Director

Mr. Mohammed Kabeer Moolian (DIN: 06844102)

: Non-Executive Independent Director

Mr. Pattassery Alavi Haji (DIN: 00251124)

: Non-Executive Director

Mr. Ali Thonikkadavath (DIN: 02905367)

: Non-Executive Independent Director

Mr. Rishin Rasheed (DIN: 09801238)

: Non-Executive Independent Director

Mr. Sivadas Chettoor (DIN: 01773249)

: Non-Executive Independent Director

Mr. Velayudhanpillai Harikumar (DIN: 10450411)

: Non-Executive Independent Director

Mr. George Chirapparambil Chacko

: Chief Financial Officer

Mrs. Heena Kausar Mohd Amin Rangari

: Company Secretary & Compliance
Officer

During the financial year 2025-2026 under review, the following changes took place in the composition of
the Board of Directors of your Company:

A. Appointments (including Additional Directors & Regularization)

Mr. Sivadas Chettoor (DIN: 01773249): Appointed as an Independent Director of the Company with
effect from
May 30, 2025.

• Mr. Rishin Rasheed (DIN: 09801238): Appointed as an Independent Director of the Company with effect
from
May 30, 2025.

Mr. Ambramoli Purushothaman (DIN: 07706484): Appointed as an Independent Director of the Company
with effect from
May 30, 2025. (Note: regularization was subsequently approved by the shareholders in
the AGM held on July 14, 2025).

Mr. Velayudhanpillai Harikumar (DIN: 10450411): Appointed to the Board as an Additional Director
(Independent) with effect from
February 12, 2026. (Note: His regularization was subsequently approved
by the shareholders via Postal Ballot on May 09, 2026).

B. Resignations / Cessations

Mr. Ambramoli Purushothaman (DIN: 07706484): Resigned from the position of Independent Director of
the Company with effect from
November 27, 2025, due to personal reasons/pre-occupations. The Board
places on record its deep appreciation for the valuable guidance and contributions rendered by him
during his tenure.

In terms of Rule 8(5)(iiia) of the Companies (Accounts) Rules, 2014, the Board of Directors has evaluated the
Independent Directors appointed during the financial year 2025-2026—namely,
Mr. Sivadas Chettoor, Mr.
Rishin Rasheed, Mr. Ambramoli Purushothaman,
and Mr. Velayudhanpillai Harikumar.

The Board is explicitly of the opinion that all the newly appointed Independent Directors possess standard
integrity, high corporate ethical values, and the necessary specialised expertise and experience across
fields such as management, trade, operational control, and corporate governance. Their inductions have
significantly strengthened the diverse skill matrix of the Board.

Furthermore, regarding the "proficiency" criteria as ascertained from the online proficiency self-assessment
test conducted by the Indian Institute of Corporate Affairs (IICA) notified under Section 150(1) of the
Companies Act, 2013, the Board confirms that:

• The Independent Directors appointed during the year are either duly registered with the Independent
Directors' Databank maintained by the IICA and have successfully qualified the online proficiency self¬
assessment test within the prescribed statutory timelines, or

• They are otherwise exempt from the requirement of clearing the said proficiency test by virtue of fulfilling
the criteria prescribed under the applicable provisions of the Companies (Appointment and
Qualification of Directors) Rules, 2014.

INDEPENDENT DIRECTORS:

A. Declaration of Independence by Independent Directors:

The Company has received the mandatory annual declarations from all the Independent Directors of the
Company confirming that they meet the strict criteria of independence as prescribed under Section 149(6)
of the Companies Act, 2013, read along with Rule 6 of the Companies (Appointment and Qualification of
Directors) Rules, 2014, and Regulation 16(1) (b) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015.

The Board of Directors has reviewed these declarations and is satisfied that the Independent Directors fulfill
all the statutory conditions specified in the Act and the Listing Regulations, and that they maintain complete
independence from the Management of the Company.

B. Separate Meeting of Independent Directors:

In accordance with the mandates of Schedule IV (Code for Independent Directors) of the Companies Act,
2013, and Regulation 25(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a
separate meeting of the Independent Directors of the Company was held during the financial year on 12th
February 2026 without the presence of Non-Independent Directors and members of the management.

During the meeting, the Independent Directors reviewed:

• The performance of Non-Independent Directors and the Board of Directors as a whole;

• The performance of the Chairperson of the Company, taking into account the views of Executive and
Non-Executive Directors; and

• The quality, quantity, and timeliness of the flow of information between the Company Management and
the Board, ensuring it is sufficient for the Board to effectively perform its duties.

C. Familiarisation Programme for Independent Directors:

Your Company has structured an onboarding and continuous training framework to keep the Independent
Directors well-informed about the corporate ecosystem. The familiarisation programme primarily focuses on
providing insights into:

• The Hospital and Healthcare Industry landscape, macroeconomic dynamics, and the socio-economic
environment in which the Company operates;

• The Company's specific healthcare delivery business model, operational infrastructure, and financial
performance trajectory; and

• Significant structural updates, regulatory changes, and their evolving roles, responsibilities, rights, and
duties under the Companies Act, 2013, and other applicable financial market statutes.

In compliance with Regulation 46(2)(i) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, the comprehensive details of the Familiarisation Programme conducted for the FY 2025¬
2026, including the exact number of programmes attended and the hours spent by individual Independent
Directors, have been uploaded on the Company's website and can be accessed at Web Link:
https://abateas.com/wp-content/uploads/2026/06/FAMILIARISATION-PROGRAMME-IMPARTED-for-FY-2025-
26.pdf

COMPOSITION OF COMMITTEES OF THE BOARD:

A. Audit committee

• Mrs. Manjusha Ramakrishnan Puthenpurakkal - Independent Director (Chairman)

• Ms. Julie G Varghese - Independent Director

• Mrs. Indu Ravindran - Independent Director

• Dr. Adv Arikuzhiyan Samsudeen - Promoter, Non-Executive Director

B. Nomination Remuneration committee

• Mrs. Manjusha Ramakrishnan Puthenpurakkal- Independent Director (Chairman)

• Ms. Julie G Varghese- Independent Director

• Mrs. Indu Ravindran - Independent Director

C. Stakeholders Relationship committee

• Mrs. Manjusha Ramakrishnan Puthenpurakkal- Independent Director (Chairman)

• Ms. Julie G Varghese- Independent Director

• Mrs. Indu Ravindran - Independent Director

NUMBER OF MEETINGS OF THE BOARD AND BOARDS' COMMITTEE:

The Board meets at regular intervals to discuss and decide on business strategies /policies and review the
financial performance of the Company. The Board Meetings are pre-scheduled, and a tentative annual
calendar of the Board is circulated to the Directors well in advance to facilitate the Directors to plan their
schedules.

Particulars

No. of Meetings during the Financial

Date of the Meeting

Year 2024-2026

30th May 2025
17th June 2025
1st August 2025

Board Meeting

7

13th August 2025
15th October 2025
10th November 2025
12th February 2026

30th May, 2025
13th Aug, 2025

Audit Committee

4

10th Nov, 2025

12th Feb, 2026

Nomination & Remuneration

2

30th May 2025

Committee

12th February 2026

Stakeholders Relationship
Committee

1

30th May, 2025

Independent Director’s Meeting

1

12th Feb, 2026

The interval between two Board Meetings was well within the maximum period mentioned under Section
173 of the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015.

The comprehensive Nomination and Remuneration Policy, detailing the complete structural parameters
and operational frameworks, is available on the official website of the Company and can be accessed by
shareholders and investors via the following direct
WEBLINK: https://abateas.com/wp-
content/uploads/2026/06/Nomination-and-Remuneration-Policy.pdf

ANNUAL EVALUATION BY THE BOARD:

The performance evaluation was conducted via a formalized questionnaire-based mechanism
administered through the Nomination and Remuneration Committee (NRC). The assessment framework
evaluated the performance of Directors across several key operational benchmarks, which included:

Attendance and Participation: Consistency of attendance at Board Meetings and respective Board
Committee Meetings.

Quality of Contribution: Substantive engagement and the value added during Board deliberations.

Strategic Perspective: Guidance, foresight, and strategic inputs provided regarding the future growth,
market trajectory, and long-term performance of the Company.

Independent Judgment: Ability to provide diverse perspectives and objective feedback extending
beyond the standard data metrics provided by the Management.

Stakeholder Commitment: Visible commitment to protecting and enhancing the long-term interests of
shareholders and other key corporate stakeholders.

The evaluation process was carried out across three distinct operational layers:

1. Performance of the Board and its Committees: The Board evaluated its own composition, structural
diversity, dynamics, frequency of meetings, and overall effectiveness. Similarly, each Committee (Audit
Committee, NRC, SRC, etc.) was assessed against its specific terms of reference and execution of
delegated statutory duties.

2. Performance of Individual Directors: A comprehensive peer-to-peer and self-assessment was executed.
To maintain complete transparency and objectivity,
each member of the Board recused themselves
and did not participate in the discussion or evaluation of his/her own performance.

3. Performance of the Chairperson: The Independent Directors, in their separate meeting, reviewed the
leadership effectiveness of the Chairperson after taking into account the feedback of both Executive
and Non-Executive Directors.

The outcomes of the evaluation process were detailed, reviewed, and discussed at length during the
subsequent Board meeting, and the overall performance was noted to be highly satisfactory.

COMPLIANCE WITH SECRETARIAL STANDARDS:

Pursuant to the provisions of Section 118(10) of the Companies Act, 2013, the Board of Directors explicitly
confirms that your Company has strictly complied with all the applicable Secretarial Standards issued and
formulated by the Institute of Company Secretaries of India (ICSI)—specifically,
Secretarial Standard-1
(SS-1)
on Meetings of the Board of Directors and Secretarial Standard-2 (SS-2) on General Meetings—during
the financial year 2025-2026 under review.

The Company maintains robust internal protocols to ensure that the processes relating to the convening,
conducting, and recording of corporate meetings are fully aligned with these statutory benchmarks.

DETAILS OF POLICIES:

The Company has the following policies which are applicable as per the Companies Act, 2013 and SEBI
(LODR) Regulations, 2015. All the policies are placed on the website of the Company.

• Code of Conduct for Directors and Senior Management Personnel.

• Code of Conduct for Insider Trading

• Code of Fair Disclosure of Unpublished Price Sensitive Information

• Web Archival Policy

• Sexual Harassment Policy

• Policy on Determination of Materiality of Events

• Policy on Nomination and Remuneration

• Policy on Preservation of Documents

• Policy on Related Party Transactions

• Policy for Board Diversity

• Whistle Blower or Vigil Mechanism Policy

• Code for Independent Directors

• Policy on Determining Material Subsidiaries.

LISTING WITH STOCK EXCHANGES:

The Equity Shares of your Company continue to remain actively listed on the BSE Limited (BSE).

In compliance with Regulation 14 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, the Company explicitly confirms that it has paid the annual listing fees to the BSE for the financial year
2025-2026 within the prescribed statutory timelines. The Company's shares have not been suspended from
trading at any point during the year, and all required corporate filings are up to date.

PARTICULARS OF CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE
EARNING AND OUTGO:

A. Conservation of energy: -

i. The steps taken or impact on conservation of energy: N.A.

ii. The steps taken by the Company for utilizing alternate sources of energy: N.A.

iii. The capital investment on energy conservation equipment: N.A.

B. Technology absorption:

i. The efforts made towards technology absorption: N.A

ii. The benefits derived like product improvement, cost reduction product development or import
substitution: N.A

iii. In case of imported technology (imported during the last three years reckoned from the beginning of
the financial year) -

a. The details of technology imported: N.A

b. The year of import: N.A

c. Whether the technology been fully absorbed. N.A.

d. If not fully absorbed, areas where absorption has not taken place & the reasons thereof; and: N.A.

iv. If not fully absorbed, areas where absorption has not taken place and the reasons thereof; and: N.A.
The expenditure incurred on Research and Development. N.A.

C. Foreign Exchange Earnings and Outgo: NIL

The Foreign Exchange earned in terms of actual inflows during the year and the Foreign Exchange
outgo during the year in terms of actual outflows.

PENALTY & FEES:

During the financial year 2025-2026 under review, neither the Company nor any of its Directors or Key
Managerial Personnel (KMP) received any material regulatory orders, show-cause notices, or compounding
directions under the Companies Act, 2013. However, as a listed entity, the Company was subject to an
administrative Standard Operating Procedure (SOP) fine imposed by BSE Limited via an order dated June
27, 2025. This fine was levied due to a procedural delay in the submission of financial results within the
prescribed statutory timelines for the quarter and financial year ended March 31,2025, as mandated under
Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Company has fully resolved this matter by paying the prescribed SOP fines on July 10, 2025. The Board
has taken note of this event, and the internal secretarial and compliance tracking mechanisms have been
further strengthened to prevent such administrative delays and ensure seamless compliance with all SEBI
timelines in the future.

RISK MANAGEMENT POLICY:

In terms of the provisions of Section 134(3)(n) of the Companies Act, 2013, the Company maintains an
internal assessment framework to identify, monitor, and mitigate key operational and business risks. The
mandatory formulation of a formal Risk Management Policy and the constitution of a standalone Risk
Management Committee under Regulation 21 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, are not applicable to the Company as it does not fall within the threshold of the top 1,000
listed entities based on market capitalization.

However, general business, financial, and operational risk factors are periodically reviewed by the
Management and overseen by the Audit Committee as part of standard corporate governance. In the
opinion of the Board of Directors, there are currently no critical elements of risk that threaten the immediate
existence or the "going concern" status of the Company.

SUCCESSION PLANNING:

The Company believes that a sound succession plan for the senior leadership is very important for creating
a robust future for the Company. The Nomination and Remuneration Committee of the Company has a
structured leadership succession plan. The Committee periodically reviews the Board composition to ensure
an appropriate balance of skills, experience, diversity, and domain expertise. In evaluating succession, the
Committee considers factors such as strategic direction, tenure and retirement timelines, and the evolving
business environment with the overarching objective of ensuring continuity and smooth transitions.

DIRECTORS' RESPONSIBILITY STATEMENT:

Pursuant to the requirement under Section 134(3)(c) of the Act, the Directors hereby confirm that:

a. in the preparation of the annual accounts for the financial year ended March 31, 2025, the applicable
accounting standards had been followed along with proper explanation relating to material departures;

b. the directors had selected such accounting policies and applied them consistently and made
judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state
of affairs of the Company at the end of the financial year ended March 31,2025 and of the profit of the
Company for that period;

c. the directors had taken proper and sufficient care for the maintenance of adequate accounting
records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of
the Company and for preventing and detecting fraud and other irregularities;

d. the directors had prepared annual accounts on a going concern basis;

e. the directors had laid down proper internal financial controls to be followed by the Company and that
such internal financial controls are adequate and operating properly, and;

f. the directors had devised proper systems to ensure compliance with the provisions of all applicable
laws and that such systems were adequate and operating effectively.

CORPORATE GOVERNANCE PHILOSOPHY:

Your Company has always believed that good corporate governance is more a way of doing business than
a mere legal compulsion. It enhances the trust and confidence of all the stakeholders. Good practice in
corporate behavior helps to enhance and maintain public trust in companies and the stock market. It is the
application of best management practices, compliances of law in true letter and spirit, and adherence to
ethical standards for effective management and discharge of social responsibilities for sustainable
development of all stakeholders. In this pursuit, your Company's philosophy on Corporate Governance is
led by a strong emphasis on transparency, fairness, independence, accountability, and integrity. The Board
plays a central role in upholding and guiding this governance framework.

VIGIL MECHANISM / WHISTLE BLOWER POLICY:

Pursuant to the provisions of Section 177(9) and (10) of the Act and Regulation 22 of the SEBI Listing
Regulations, your Company has formulated a vigil mechanism through whistle blower policy to deal with
instances of unethical behaviour, actual or suspected fraud, violation of Company's code of conduct or
policy. No person has been denied access to the Chairman of the Audit Committee. The details of the
policy are posted on the website of the Company.

CODE FOR PROHIBITION OF INSIDER TRADING:

Your Company has adopted a code of conduct to regulate, monitor, and report trading by designated
persons and their immediate relatives as per the requirement under the Securities and Exchange Board of
India (Prohibition of Insider Trading) Regulations, 2015. This code also includes code for practices and
procedures for fair disclosure of unpublished price sensitive information which has been made available on
the website of the Company.

DISCLOSURE UNDER SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND
REDRESSAL) ACT, 2013:

Your Company is committed to providing a safe, secure, and conducive work environment that treats all
employees with dignity, respect, and equality. In line with the statutory mandates, the Company has strictly
complied with the provisions relating to the constitution of the Internal Complaints Committee (ICC) under
the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. The
Committee has been established across all administrative offices and operational units to resolve, prevent,
and redress any complaints of sexual harassment at the workplace.

During the financial year 2025-2026 under review, the status of complaints received and disposed of by the
Internal Complaints Committee is as follows:

• Number of complaints pending at the beginning of the financial year: Nil

• Number of complaints received during the financial year: Nil

• Number of complaints disposed of during the financial year: Nil

• Number of complaints pending at the end of the financial year: Nil

WEBLINK: https://abateas.com/wp-content/uploads/2026/06/Sexual-Harassment-Policy.pdf

DISCLOSURES UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016:

In accordance with Rule 8(5)(xi) of the Companies (Accounts) Rules, 2014, the Board of Directors confirms
that there were no applications made or any corporate proceedings initiated or pending against the
Company under the Insolvency and Bankruptcy Code, 2016 (IBC) during the financial year 2025-2026.
Furthermore, your Company has not been subject to any corporate insolvency resolution processes or
related liquidations at the close of the financial year.

DETAILS OF ONE-TIME SETTLEMENT WITH BANKS OR FINANCIAL INSTITUTIONS:

Pursuant to Rule 8(5) (xii) of the Companies (Accounts) Rules, 2014, your Company reports that it has not
entered into any One-Time Settlement (OTS) with any Banks, Financial Institutions, or institutional lenders
during the financial year under review. Consequently, the disclosure of any differences between the
valuation done at the time of such a settlement and the valuation conducted while originally taking loans
from lenders, along with reasons thereof, is not applicable.

COMPLIANCE WITH THE MATERNITY BENEFIT ACT, 1961:

Your Company is dedicated to upholding a progressive, inclusive, and legally compliant workplace
environment for its workforce. The Company explicitly confirms that it has strictly complied with all
applicable statutory provisions, rules, and guidelines relating to the Maternity Benefit Act, 1961 (including all
subsequent structural amendments). The prescribed healthcare facilities, paid leave benefits, and career
security measures are fully extended to eligible female employees across all administrative and operational
units of the Company, and no instances of non-compliance or grievances were recorded during the
financial year 2025-2026.

CORPORATE SOCIAL RESPONSIBILITY:

A. Statutory Applicability and Reporting Status:

During the financial year 2025-2026 under review, the statutory thresholds prescribed under Section 135(1)
of the Companies Act, 2013, read along with the Companies (Corporate Social Responsibility Policy) Rules,
2014, were not attracted or breached by your Company.

Consequently, the provisions relating to mandatory expenditures and the constitution of a standalone
Corporate Social Responsibility Committee are not applicable to the Company for the period under report.
Accordingly, a formal annual report on CSR activities is not annexed to this Board's Report.

B. CSR Policy and Web Link:

During the financial year 2025-2026 under review, the statutory thresholds prescribed under Section 135(1)
of the Companies Act, 2013, read along with the Companies (Corporate Social Responsibility Policy) Rules,
2014, were not attracted or breached by your Company.

Consequently, the provisions relating to the mandatory constitution of a Corporate Social Responsibility
Committee, formulation of a CSR policy, and statutory expenditures are not applicable to the Company for
the period under report. Accordingly, a formal annual report on CSR activities is not annexed to this Board's
Report.

DISCLOSURE/ ANNEXURES:

a. Annual Return:

Pursuant to provisions of Section 92(3) and Section 134(3) (a) of the Act, the submission of extract of the
Annual Return in the form MGT-9 has been dispensed with in terms of the Companies (Management
and Administration) Amendment Rules, 2021 dated March 05, 2021. Hence, the form MGT-9 has not
been attached with the Board Report. However, the Company has placed a copy of the Annual
Return on its website. Weblink:
https://abateas.com/annual-returns/

b. Report on Corporate Governance:

The report on corporate governance as stipulated under Chapter V of the SEBI Listing Regulations forms
an integral part of this report.

c. Certificate of Non-Disqualification of Directors:

Pursuant to Regulation 34(3) and Schedule V, Para C Clause (10)(i) of the SEBI Listing Regulations, the
Certificate of Non-Disqualification of Directors for the financial year ended March 31, 2026, obtained
from M/s. Lakshmmi Subramanian & Associates, Practising Company Secretaries, forms an integral part
of this report.

d. Management Discussion and Analysis Report:

The Management Discussion and Analysis Report for the year under review, as stipulated under
Regulation 34 of the SEBI Listing Regulations, forms an integral part of this report.

e. Certificate by WTD and CFO:

Mr Muhemmed Swadique, Whole-Time Director and Mr George Chirapparamnil Chacko, Chief
Financial Officer, have submitted the certificate, in terms of Regulation 17(8) read with Part B of
Schedule II of the SEBI Listing Regulations, to the Board. The certificate forms an integral part of this
report.

f. Code of Conduct for Board of Directors and Senior Management:

The Company has formulated a Code of Conduct for the Board of Directors and Senior Management
and has complied with all the requirements mentioned in the aforesaid code. A declaration to this
effect has been signed by Dr Adv. A. Samsudeen, Chairman of the Company and forms part of this
Annual Report.

g. Related Party Transactions:

All related party transactions during the FY 2025-26 were in the ordinary course of business and at arm's
length basis. There are no materially significant related party transactions during the year, which, in the
opinion of the Board, may have potential conflicts with the larger interests of the Company. The Audit
Committee has reviewed on a quarterly basis the related party transactions of the Company and the
particulars of contracts or arrangements or transactions with related parties during the FY 2025-26, as
referred to in Section 188(1) and applicable rules of the Act in Form AOC-2, which forms an integral part
of this report.

AUDIT AND AUDITORS:

a. Statutory Auditor & Audit Report

The Members of the Company, in its 31st AGM held on September 7, 2022, appointed M/s. Mahesh C
Solanki & Co., Chartered Accountants (Firm Registration No. CR2052) as Statutory Auditors of the
Company, for a period of five years, to hold office from the conclusion of the 31st AGM till the
conclusion of the 36th AGM.

The report given by the Statutory Auditors, on the standalone and consolidated financial statements of
the Company for the financial year ended March 31, 2026 forms part of this Annual Report. The
comments on the statement of accounts referred to in the Audit Report are self-explanatory. The Audit
Report does not contain any qualification, reservation, or adverse remark.

b. Secretarial Auditor and its Report

Secretarial Audit Report of Abate AS Industries Limited

Pursuant to the provisions of Section 204 of the Act and the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014 and Regulation 24A of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,the Company has
appointed M/s. Lakshmmi Subramanian & Associates, Practicing Company Secretaries, as Secretarial
Auditors of the Company for the period of five year, to hold office from the conclusion of the 34th AGM
till the conclusion of the 39th AGM.

The report given by the Secretarial Auditors for the financial year ended March 31, 2026 forms part of
this Annual Report. The Secretarial Audit Report does not contain any qualification, reservation, or
adverse remark.

Secretarial Audit Report of Salamath Import And Exports Private Limited and Prudential Management
Service Private Limited

Pursuant to Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, Secretarial Audit applies to our two material subsidiaries, i.e.
Salamath Import and Exports Private Limited & Prudential Management Services Private Limited.

Accordingly, Mrs. Manjula Poddar, Practicing Company Secretary, was appointed as Secretarial
Auditor to undertake the Secretarial Audit of the material Subsidiaries Company for the financial year
2025-26. The Secretarial Audit Report for the said year of material Subsidiaries
SALAMATH IMPORT AND
EXPORTS PRIVATE LIMITED and PRUDENTIAL MANAGEMENT SERVICE PRIVATE LIMITED
is annexed to this
Report. The Secretarial Audit Report does not contain any qualification, reservation, or adverse remark.

c. Cost Audit and Cost Records:

Maintenance of cost records and requirement of Cost Audit as prescribed under Section 148(1) of the
Act read with Companies (Cost Records and Audit) Rules, 2014 is not applicable to the business
activities carried out by your Company.

d. Reporting of fraud by Auditors

During the year under review, neither the Statutory Auditor nor the Secretarial Auditor has reported, to
the Audit Committee, any instances of fraud committed against the Company by its officers or
employees, under Section 143(12) of the Act. Therefore, no detail is required to be disclosed under
Section 134(3) (ca) of the Act.

PARTICULARS OF EMPLOYEES:

None of the employees of the Company were in receipt of remuneration in excess of limits pursuant to
Section 197 of the Act read with Rule 5 of the Companies (Appointment and Remuneration of Managerial
personnel) Rules 2014.

The disclosures prescribed under Section 197(12) of the Companies Act, 2013, read with Rule 5(1) of the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are disclosed in the
Annexure, and form part of this Annual Report.

The Statement showing the remuneration drawn by the top ten employees for the Financial Year 2025-26:
The Company does not have any employee:

• who has received remuneration during the financial year, which in aggregate exceeds ' 1.02 Cr.

• who was employed for the part of the year and was in receipt of remuneration for any part of that year
exceeding '8.50 Lakhs per month.

• who received remuneration in excess of that drawn by the Managing Director or Whole-time Director or
Manager and held by himself or along with his spouse and dependent children, not less than two per
cent of the equity shares of the Company.

It is hereby affirmed that the remuneration to the employees is as per the remuneration policy of the
Company.

ACKNOWLEDGEMENTS:

Your Directors would like to express their appreciation for assistance and co-operation received from the
financial institutions, banks, Government authorities, customers, shareholders, suppliers, business
partners/associates during the year under review. Your Directors also wish to place on record their deep
sense of appreciation for the services committed by the management team and other employees of the
Company.

CAUTIONARY STATEMENT:

All statements that address expectations or projections about the future, including, but not limited to
statements about the Company's strategy for growth, product development, market position, expenditures
and financial results are forward- looking statements. Forward looking statements are based on certain
assumptions and expectations of future events. The Company cannot guarantee that these assumptions
and expectations are accurate or will be realized. The Company's actual results, performance or
achievements could thus differ materially from those projected in any such forward looking statements. The
Company assumes no responsibility to publicly amend, modify or revise any forward-looking statements, on
the basis of any subsequent developments, information or events.

Date: 13-08-2026 By order of the Board of Directors

Place: Perinthalmanna For Abate AS Industries Limited

(Formerly Known as Trijal Industries Limited)

Dr. Adv. A. Samsudeen

(DIN: 01812828)

Chairman & Non-Executive Director

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.